Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Ashraf H Abadi

Ashraf H Abadi

German University in Cairo Egypt

Dilip K Ghosh

Dilip K Ghosh

Nutriconnect Australia

Angela Drew

Angela Drew

Camargo Pharmaceutical Services USA

Sadish Kumar Shanmugam

Sadish Kumar Shanmugam

ITS College of Pharmacy India

Martha Rowe

Martha Rowe

Rowe’s Speech and Swallowing Australia

Godfrey Habil Mudhune

Godfrey Habil Mudhune

Western Sydney University’s Translational Health Research Institute Australia

Venkateshwarlu K

Venkateshwarlu K

Vaagdevi College of Pharmacy India

Saraswathi Sompaga

Saraswathi Sompaga

Osmania University India

Asia Pharma 2019

About Conference


The 20th Asia-Pacific Pharma Congress will exhibit the products and services from commercial and non-commercial organizations like Drug manufactures, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

Asia Pharma 2019 Conference is a multidisciplinary program with expansive cooperation with individuals from around the world concentrated on finding out about Pharma Research and its advances. This is your best chance to achieve the biggest gathering of members in our Pharma conference from the scholarly world, inquire about substances, medicinal gatherings, related affiliations, social orders and furthermore from government organizations, pharmaceutical and biomedical research.

Meet your target market with individuals from around the globe concentrated on finding out about Pharma, this is your single best chance to achieve the biggest array of members in our Pharma conference. Direct showings, disperse data, meet with flow and potential Scientists, make a sprinkle with another examination, and get name acknowledgment at this 3-day Pharmaceutical Event. Incredibly famous speakers, the latest methods, strategies, and the most up to date refreshes in Pharmaceutical Sciences fields are signs of this meeting.

Sessions

Market Analysis

Why Tokyo, Japan?

Tokyo is Japan's capital and the world's most populous metropolis. It is also one of Japan's 47 prefectures, consisting of 23 central city wards and multiple cities, towns and villages west of the city center. The Izu and Ogasawara Islands are also part of Tokyo. It has neon, skyscrapers, salaryman crowds, packed trains, cutting-edge architecture and futuristic technology. But it also has ancient shrines, plant-covered wooden houses, cycling grannies, old-school sweet shops and village-like lanes.

Tokyo is a nirvana for foodies and has the world’s highest volume of Michelin stars in a city. Shopping is another highlight – it’s worth bringing an empty suitcase to fill with hard-to-resist gadgets, trendsetting garments and treasures from craft and design stores. And now there’s another reason to visit: the 2020 summer Olympics will take place in Tokyo. As a result, not only is the mood refreshingly upbeat, but a raft of new developments, hotels and infrastructure upgrades are in the pipeline.

With more than 12.5 million residents to entertain, Tokyo has a lot going on. Boasting the Tokyo National Museum, the National Museum of Nature and Science, the Ueno Zoo, and the sprawling green space, Ueno Park are the special places to visit in Tokyo. Edo-Tokyo Museum and the Imperial Palace resembles the history of Tokyo. And no trip here would be complete without visiting some of Tokyo's Buddhist and Shinto sites like the Sensoji Temple and the Meiji Shrine.

Japan continues to be one of the largest pharmaceutical markets in the world despite a challenging business landscape due to demographics. According to the latest official figures from the Ministry of Health, Labor and Welfare (MHLW)’s Annual Pharmaceutical Production Statistics, the Japanese market for prescription and nonprescription pharmaceuticals in 2015 totaled $88 billion (up 10.7% from 2014 in yen terms). More than 90% of the total market consists of prescription pharmaceuticals. Imports of foreign pharmaceuticals accounted for approximately 38% of the total Japanese market in 2015. Japan’s total imports of U.S. pharmaceuticals totaled $5.7 billion in 2015, a 6% market share. However, the total market share of U.S.-origin pharmaceuticals, i.e., including local production by US firms and US-owned compounds licensed to Japanese manufacturers approaches 20%. The size of the market is expected to increase in a measured fashion for the foreseeable future due to continued demands for drugs from Japan’s aging population and the rising number of chronic and long-term diseases. However, in the short term, the market may see limited growth due to pricing environment which could become more challenging.

Contrary to these positive developments, strong financial pressure is simultaneously growing for the GOJ to contain healthcare spending in the country due to the rapid aging of Japan's population. In JFY 2014, national health expenditures hit another record at Yen 40.81 trillion (U.S.D 337.1 billion at U.S.D1=JPY121.05). Nearly 58.6%of all medical expenditures were for elderly patients over the age of 65. MHLW estimates that the healthcare expenditure will reach Yen 54 trillion by 2015. As a result, the GOJ is expected to continue addressing immediate budget short falls by cutting prices for pharmaceuticals. In late December 2016, the GOJ’s Council on Economic and Fiscal Policy (CEFP) and four Ministers announced a basic plan to overhaul the drug pricing mechanism. The basic plan calls for some significant changes from the current pricing system such as reviewing drug prices four times a year if the particular drug saw an expansion of market size due to indication additions; conducting drug price surveys every year from the current biennial cycle; and reviewing the pricing premium for the promotion of new drug development (so called ‘Price Premium System’) on a zero basis. The implementation of the Price Premium System in 2010 was a major positive development for pharmaceutical firms as it provides a predictable and stable pricing environment for innovative drugs throughout the life of the patent. Since the premium pricing system was implemented, there has been a significant decrease in the submission lag and a significant increase in the number of drugs developed in Japan. As such, the “zero-based” review of the price maintenance premium may have significant implications for foreign drug makers with innovative drugs depending on the scope of revision. The GOJ began holding discussions on the details of the planned drug pricing overhaul in January 2017 with a framework of pricing reform to be drawn by the end of 2017.

Past Conference Report

Asia Pharma 2018

Conference Series LLC successfully anchored its leading "15th Asia-Pacific Pharma Congress" slated on July 18-20, 2018 at Mercure Melbourne Albert Park in Melbourne, Australia.

Asia Pharma 2018 is distinguished with the attendance of Editorial Board Members of supported Journals, Scientists, Young and Brilliant Researchers, Business Delegates and Talented Student communities representing more than 25 countries who made this conference rewarding and fecund.

Our 15th Asia-Pacific Pharma Congress was based on the theme “De Novo Advancements in Pharmaceutical Sciences” which has encrusted the below scientific sessions:

  • Regulatory Affairs and Intellectual Property Rights
  • Pharmacognosy and Phytochemistry
  • Pharmaceutics and Pharmacotherapeutics
  • Nanomedicine and Nanotechnology
  • Industrial and Physical Pharmacy
  • Pharmacology and Toxicology
  • Pharmaceutical Chemistry
  • Pharmaceutical Analysis
  • Pharmaceutical Microbiology
  • Pharmaceutical Biotechnology
  • Biochemistry and Molecular Biology
  • Clinical and Hospital Pharmacy
  • Nutraceuticals and Natural Medicine
  • Drug Safety and Pharmacovigilance
  • Clinical Trials and Research
  • Green and Community Pharmacy
  • Pharmacogenetics and Genomics
  • Pharmacy Education and Practice
  • Pharmaceutical Care and Health Systems
  • Pharma Manufacturing and Compliance

The conference received salutations & immense support was extended by the keynote lectures mentioned below:

  • Dilip K Ghosh, Nutriconnect, Australia
  • Ashraf H Abadi, The German University in Cairo, Egypt
  • Sadish Kumar Shanmugam, ITS College of Pharmacy, India

Conference Series LLC Ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, Poster presenters, students, delegates and special thanks to the Media Partners (Events Get, Medical Events Guide, Placid Way, Atlas of Science, Pharma Voice, Pink Medico, Technology Networks, The Pharma Review, Crowd Reviews, Bio-Equip, Asian Hospital & Healthcare Management, Kind Congress, Tabeeby, Pharma Focus Asia and Pharmaceutical Tech.com) for their promotion to make this event a huge success.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Pharmaceutical Research. Conference Series LLC ltd therefore, is glad to announce its 20th Asia-Pacific Pharma Congress slated on May 20-22, 2019 in Tokyo, Japan.

 Mark your calendars for the upcoming meeting; we are hoping to see you soon!!!!


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 22-24, 2019

Speaker Opportunity

Supported By

Journal of Pharmaceutical Care & Health Systems Journal of Hospital and Clinical Pharmacy Journal of Pharmaceutical Microbiology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by